Presentation Information
[O7-04]T細胞応答増強効果と安全性向上を両立したサイトカイン併用型mRNAがんワクチンの開発
*Wakana Inoue1,2, Tatsuya Karaki2,3, Toshiro Hirai1,2,4,5, Yasuo Yoshioka1,2,3,4,5 (1. Graduate School of Pharmaceutical Sciences, The University of Osaka, 2. Research Institute for Microbial Diseases, The University of Osaka, 3. The Research Foundation for Microbial Diseases of Osaka University, 4. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 5. Center for Advanced Modalities and DDS, The University of Osaka /CAMaD, Osaka Univ.)